Filing Flows › Comparisons › TEVA vs VRTX
Teva Pharmaceutical Industries vs Vertex Pharmaceuticals: TEVA and VRTX compared
Teva Pharmaceutical Industries is the larger company: $4.4B of revenue in its latest quarter (Q3 2026) against $3.4B for Vertex Pharmaceuticals (Q3 2026). Vertex Pharmaceuticals is growing faster (+12% against -2% a year earlier). Vertex Pharmaceuticals is more profitable, with an operating margin of 20.7% against 16.2%.
Where the money goes: TEVA and VRTX
Teva Pharmaceutical Industries (TEVA) · Q3 2026
Teva Pharmaceutical Industries, Q3 2026: revenue $4.4B (-2% year over year), operating margin 16.2%, net earnings $234M, operating cash flow $241M. The chart follows the revenue to costs, profit and cash.
Vertex Pharmaceuticals (VRTX) · Q3 2026
Vertex Pharmaceuticals, Q3 2026: revenue $3.4B (+12% year over year), operating margin 20.7%, net earnings $654M, operating cash flow $643M. The chart follows the revenue to costs, profit and cash.
| Teva Pharmaceutical Industries (TEVA) | Vertex Pharmaceuticals (VRTX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $4.4B | $3.4B |
| Revenue growth, Y/Y | -2% | +12% |
| Gross margin | 55.5% | — |
| Operating margin | 16.2% | 20.7% |
| Net earnings | $234M | $654M |
| Net margin | 5.3% | 19.0% |
| Operating cash flow | $241M | $643M |
| Free cash flow | $121M | $546M |
| Market value | $49.4B | $139.6B |
| P/E | 95.0× | 35.2× |
| Analysts’ mean target | $49.08 | $592.36 |
Where the revenue comes from
Teva Pharmaceutical Industries
- Sale of goods: $3.7B (85%)
- Distribution: $421M (10%)
- Other: $184M (4%)
- Licensing arrangements: $49.0M (1%)
Vertex Pharmaceuticals
- Total CF product revenues, net: $3.3B (95%)
- CASGEVY: $99.2M (3%)
- JOURNAVX: $58.3M (2%)
Questions
Which is bigger, Teva Pharmaceutical Industries or Vertex Pharmaceuticals?
Teva Pharmaceutical Industries is the larger company: $4.4B of revenue in its latest quarter (Q3 2026) against $3.4B for Vertex Pharmaceuticals (Q3 2026).
Is Teva Pharmaceutical Industries or Vertex Pharmaceuticals growing faster?
Vertex Pharmaceuticals is growing faster (+12% against -2% a year earlier).
Which is more profitable, Teva Pharmaceutical Industries or Vertex Pharmaceuticals?
Vertex Pharmaceuticals is more profitable, with an operating margin of 20.7% against 16.2%.
More: Teva Pharmaceutical Industries earnings · how Teva Pharmaceutical Industries makes money · Vertex Pharmaceuticals earnings · how Vertex Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 3, 2026; 10-Q filed Nov 3, 2026). Fiscal quarters can end on different dates. Not investment advice.